For research use only. Not for therapeutic Use.
Cefozopran hydrochloride（Cat No.:I000527）is a broad-spectrum cephalosporin antibiotic used for the treatment of various bacterial infections, including those caused by Gram-positive and Gram-negative pathogens. It works by inhibiting bacterial cell wall synthesis, leading to cell lysis and bacterial death. Cefozopran hydrochloride is particularly effective against respiratory, urinary tract, and skin infections. It is often utilized in hospital settings for severe infections. Its formulation as a hydrochloride salt enhances its solubility and stability, making it suitable for intravenous and intramuscular administration.
| Catalog Number | I000527 |
| CAS Number | 113981-44-5 |
| Molecular Formula | C19H17N9O5S2•HCl |
| Purity | ≥95% |
| Target | Bacterial |
| Solubility | H2O: ＞ 52 mg/mL |
| Storage | under inert gas (nitrogen or Argon) at 2-8°C |
| IUPAC Name | (6R,7R)-7-[[(2Z)-2-(5-amino-1,2,4-thiadiazol-3-yl)-2-methoxyiminoacetyl]amino]-3-(imidazo[1,2-b]pyridazin-1-ium-1-ylmethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate;hydrochloride |
| InChI | InChI=1S/C19H17N9O5S2.ClH/c1-33-24-11(14-23-19(20)35-25-14)15(29)22-12-16(30)28-13(18(31)32)9(8-34-17(12)28)7-26-5-6-27-10(26)3-2-4-21-27;/h2-6,12,17H,7-8H2,1H3,(H3-,20,22,23,25,29,31,32);1H/b24-11-;/t12-,17-;/m1./s1 |
| InChIKey | NTJHUKMPVIFDNY-XFDPNJHTSA-N |
| SMILES | CO/N=C(/C1=NSC(=N1)N)\C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)C[N+]4=C5C=CC=NN5C=C4)C(=O)[O-].Cl |
| Reference | <p style=/line-height:25px/> |
